Effect of artificial tears on tear stress test

Optometry and Vision Science

Volumn 85, Issue 8, 2008, Pages 732-739

  Khanal, Santosh ^a   Simmons, Peter A ^b   Pearce, Edward I ^a   Day, Mhairi ^a   Tomlinson, Alan ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b ALLERGAN INC   (United States)

Author keywords

Artificial tears; Computer vision syndrome; Environmental dry eye; Ocular stress; Visual display terminal (VDT) use

Indexed keywords

ARTIFICIAL TEARS; BREAK-UP; CROSS-OVER; DRY EYE; ENVIRONMENTAL DRY EYE; LOW CONTRAST; LOW VISCOSITY; NON-INVASIVE; OCULAR STRESS; PRE-STRESS; TEAR STRESS; TEST CONDITION; TEST SOLUTIONS; VISUAL ACUITY; VISUAL DISPLAY TERMINAL (VDT) USE;

COMPUTER VISION; EVAPORATION; STRESS RELIEF; VAPORS; VISCOSITY; VISION;

TESTING;

ARTIFICIAL TEAR; EYE DROPS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRY EYE; EVAPORATION; EXERCISE TEST; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SYMPTOMATOLOGY; TEAR STRESS TEST; VALIDATION STUDY; VISCOSITY; VISUAL ACUITY; VISUAL ANALOG SCALE; AIR QUALITY CONTROL; BIOLOGICAL MODEL; BLINKING; CHEMISTRY; CLINICAL TRIAL; COMPUTER TERMINAL; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; LACRIMAL FLUID; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL SYSTEM EXAMINATION;

ADULT; ATMOSPHERE EXPOSURE CHAMBERS; BLINKING; COMPUTER TERMINALS; CONTRAST SENSITIVITY; CROSS-OVER STUDIES; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DOUBLE-BLIND METHOD; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; TEARS; TREATMENT OUTCOME; VISCOSITY; VISUAL ACUITY;

EID: 52049103903     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e318181ae1c     Document Type: Article

References (48)

1. Lemp M, Baudouin C, Baum J, Dogru M, Foulks GN, Kinoshita S, Laibson P, McCulley J, Murube J, Pfugfelder SC, Rolando M, Toda I. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:75-92.
2. Albietz JM. Dry eye: an update on clinical diagnosis, management and promising new treatments. Clin Exp Optom 2001;84:4-18.
3. Hikichi T, Yoshida A, Fukui Y, Hamano T, Ri M, Araki K, Horimoto K, Takamura E, Kitagawa K, Oyama M, Danjo Y, Kondo S, Fujishima H, Toda I, Tsubota K. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol 1995;233:555-8.
4. Schlote T, Kadner G, Freudenthaler N. Marked reduction and distinct patterns of eye blinking in patients with moderately dry eyes during video display terminal use. Graefes Arch Clin Exp Ophthalmol 2004;242:306-12.
5. Backman H, Haghighat F. Indoor-air quality and ocular discomfort. J Am Optom Assoc 1999;70:309-16.
6. Holly FJ. Modern tear substitutes in the primary care of dry eye. Optom Today January/February 25,1992.
7. Nepp J, Schauersberger J, Schild G, Jandrasits K, Haslinger-Akramian J, Derbolav A, Wedrich A. The clinical use of viscoelastic artificial tears and sodium chloride in dry-eye syndrome. Biomaterials 2001;22:3305-10.
8. Khanal S, Tomlinson A, Pearce EI, Simmons PA. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye. Cornea 2007;26:175-81.
9. Rieger G. Lipid-containing eye drops: a step closer to natural tears. Ophthalmologica 1990;201:206-12.
10. Korb DR, Scaffidi RC, Greiner JV, Kenyon KR, Herman JP, Blackie CA, Glonek T, Case CL, Finnemore VM, Douglass T. The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms. Optom Vis Sci 2005; 82:594-601.
11. Prabhasawat P, Tesavibul N, Kasetsuwan N. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study. Br J Ophthalmol 2007;91:47-50.
12. Skilling FC Jr, Weaver TA, Kato KP, Ford JG, Dussia EM. Effects of two eye drop products on computer users with subjective ocular discomfort. Optometry 2005;76:47-54.
13. Maruyama K, Yokoi N, Takamata A, Kinoshita S. Effect of environmental conditions on tear dynamics in soft contact lens wearers. Invest Ophthalmol Vis Sci 2004;45:2563-8.
14. Pan Z, Zhao L, Guo D, Yang R, Xu C, Wu X. [Effects of oral calcium supplementation on blood pressure in population]. Zhonghua Yu Fang Yi Xue Za Zhi 2000;34:109-12.
15. Walinder R, Ernstgard L, Johanson G, Norback D, Venge P, Wieslander G. Acute effects of a fungal volatile compound. Environ Health Perspect 2005;113:1775-8.
16. Sheedy JE, Hayes JN, Engle J. Is all asthenopia the same? Optom Vis Sci 2003;80:732-9.
17. Brown B, Lovie-Kitchin JE. High and low contrast acuity and clinical contrast sensitivity tested in a normal population. Optom Vis Sci 1989;66:467-73.
18. Hirji N, Patel S, Callander M. Human tear film pre-rupture phase time (TP-RPT)-a non-invasive technique for evaluating the pre-corneal tear film using a novel keratometer mire. Ophthalmic Physiol Opt 1989;9:139-42.
19. Trees GR, Tomlinson A. Effect of artificial tear solutions and saline on tear film evaporation. Optom Vis Sci 1990;67:886-90.
20. Tomlinson A, Pearce EI, Simmons PA, Blades K. Effect of oral contraceptives on tear physiology. Ophthalmic Physiol Opt 2001;21: 9-16.
21. Tsubota K, Nakamori K. Effects of ocular surface area and blink rate on tear dynamics. Arch Ophthalmol 1995;113:155-8.
22. Palakuru JR, Wang J, Aquavella JV. Effect of blinking on tear dynamics. Invest Ophthalmol Vis Sci 2007;48:3032-7.
23. Begley CG, Himebaugh N, Renner D, Liu H, Chalmers R, Simpson T, Varikooty J. Tear breakup dynamics: a technique for quantifying tear film instability. Optom Vis Sci 2006;83:15-21.
24. Henriquez VM, Evinger C. Modification of cornea-evoked reflex blinks in rats. Exp Brain Res 2005;163:445-56.
25. Yap M. Tear break-up time is related to blink frequency. Acta Oph-thalmol (Copenh) 1991;69:92-4.
26. Prause JU, Norn M. Relation between blink frequency and break-up time? Acta Ophthalmol (Copenh) 1987;65:19-22.
27. Blehm C, Vishnu S, Khattak A, Mitra S, Yee RW. Computer vision syndrome: a review. Surv Ophthalmol 2005;50:253-62.
28. Best PS, Littleton MH, Gramopadhye AK, Tyrrell RA. Relations between individual differences in oculomotor resting states and visual inspection performance. Ergonomics 1996;39:35-40.
29. Gratton I, Piccoli B, Zaniboni A, Meroni M, Grieco A. Change in visual function and viewing distance during work with VDTs. Ergonomics 1990;33:1433-41.
30. Gur S, Ron S, Heicklen-Klein A. Objective evaluation of visual fatigue in VDU workers. Occup Med (Lond) 1994;44:201-4.
31. Acosta MC, Gallar J, Belmonte C. The influence of eye solutions on blinking and ocular comfort at rest and during work at video display terminals. Exp Eye Res 1999;68:663-9.
32. Nakaishi H, Yamada Y. Abnormal tear dynamics and symptoms of eyestrain in operators of visual display terminals. Occup Environ Med 1999;56:6-9.
33. Shahnavaz H, Hedman L. Visual accommodation changes in VDU-operators related to environmental lighting and screen quality. Ergonomics 1984;27:1071-82.
34. Sheedy JE. Vision problems at video display terminals: a survey of optometrists. J Am Optom Assoc 1992;63:687-92.
35. Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 1997;104: 1395-401.
36. Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Oph-thalmol 2003;31:229-32.
37. Hay EM, Thomas E, PalB,Hajeer A, Chambers H, Silman AJ. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998;57:20-4.
38. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea 2004;23:272-85.
39. Bron AJ, Bron AJ, Abelson MB, Ousler G, Pearce E, Tomlinson A, Yokoi N, Smith JA, Begley C, Caffery B, Nichols K, Schaumberg D, Schein O, Calonge M, Baudouin C, Goto E, Grus F, Paugh J Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:108-52.
40. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-32.
41. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis BL. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998;17:38-56.
42. Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124: 723-8.
43. Dalzell MD. Dry eye: prevalence, utilization, and economic implications. Manag Care 2003;12:9-13.
44. Foulks GN. The evolving treatment of dry eye. Ophthalmol Clin North Am 2003;16:29-35.
45. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000;107:631-9.
46. Simmons PA, Vehige JG. Clinical performance of a mid-viscosity artificial tear for dry eye treatment. Cornea 2007;26:294-302.
47. Wang IJ, Lin IC, Hou YC, Hu FR. A comparison of the effect of carbomer-, cellulose- and mineral oil-based artificial tear formulations. Eur J Ophthalmol 2007;17:151-9.
48. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 2000;107:967-74.